| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d7e470e09803bd6bf24b2fd176109dd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2012-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8990ac54718094859742cb42c9804e76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb12c0829c0c6572f3e631bbf66b5219 |
| publicationDate |
2015-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-104363909-A |
| titleOfInvention |
Use of fapixate for the treatment of attention deficit hyperactivity disorder |
| abstract |
The present invention relates to the treatment of attention deficit hyperactivity disorder with α-phenyl(piperidin-2-yl)methanol or pharmaceutically acceptable salts and esters thereof, in particular acetate derivatives, more in particular dexfaperidin (ADHD). In addition, the present invention relates to a process for the synthesis of the (S,S) enantiomer of α-phenyl(piperidin-2-yl)methanol and a process for the synthesis of dexfaperidate. |
| priorityDate |
2011-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |